A randomized controlled study to examine the effects of a triple therapy with vonoprazan or rabeprazole against standard triple therapy-failed patients

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2015
INTERVENTION: vonoprazan, metronidazole, amoxicillin rabeprazole, metronidazole, amoxicillin CONDITION: Helicobacter pylori infection PRIMARY OUTCOME: Comparison on an eradication rate between a triple therapy with vonoprazan and a triple therapy with rabeprazole SECONDARY OUTCOME: Comparison of adverse effects between a triple therapy with vonoprazan and a triple therapy with rabeprazole INCLUSION CRITERIA: Patients who failed standard triple therapy
Epistemonikos ID: 52ef81e5cb2916fa59998b8c1708b55f6877a62a
First added on: Aug 23, 2024